Article Details
Retrieved on: 2021-07-26 06:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca announced on Monday that 'Ultomiris', or ravulizumab, has been recommended for marketing authorisation in the European Union for ...
Article found on: www.sharecast.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here